BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3792404)

  • 1. Efficacy of DSIP to normalize sleep in middle-aged and elderly chronic insomniacs.
    Schneider-Helmert D
    Eur Neurol; 1986; 25(6):448-53. PubMed ID: 3792404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia.
    Schneider-Helmert D
    Eur Neurol; 1987; 27(2):120-9. PubMed ID: 3622582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of delta sleep-inducing peptide efficacy in improving sleep on short-term administration to chronic insomniacs.
    Monti JM; Debellis J; Alterwain P; Pellejero T; Monti D
    Int J Clin Pharmacol Res; 1987; 7(2):105-10. PubMed ID: 3583493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DSIP in sleep disturbances.
    Schneider-Helmert D
    Eur Neurol; 1986; 25 Suppl 2():154-7. PubMed ID: 3758119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep.
    Schneider-Helmert D; Schoenenberger GA
    Experientia; 1981; 37(9):913-7. PubMed ID: 7028502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of DSIP in man. Multifunctional psychophysiological properties besides induction of natural sleep.
    Schneider-Helmert D; Schoenenberger GA
    Neuropsychobiology; 1983; 9(4):197-206. PubMed ID: 6689058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of DSIP (delta sleep-inducing peptide) in the correction of phase-shifted insomnia].
    Schneider-Helmert D; Hermann E; Schoenenberger GA
    Dtsch Med Wochenschr; 1987 Jun; 112(23):922-5. PubMed ID: 3582201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study.
    Bes F; Hofman W; Schuur J; Van Boxtel C
    Neuropsychobiology; 1992; 26(4):193-7. PubMed ID: 1299794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DSIP in insomnia.
    Schneider-Helmert D
    Eur Neurol; 1984; 23(5):358-63. PubMed ID: 6391925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic delta-sleep-inducing peptide improves sleep in insomniacs.
    Schneider-Helmert D; Graf M; Schoenenberger GA
    Lancet; 1981 Jun; 1(8232):1256-7. PubMed ID: 6112579
    [No Abstract]   [Full Text] [Related]  

  • 11. A clinical trial with DSIP.
    Kaeser HE
    Eur Neurol; 1984; 23(5):386-8. PubMed ID: 6391926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and tolerability of Baldrian versus oxazepam in non-organic and non-psychiatric insomniacs: a randomised, double-blind, clinical, comparative study].
    Dorn M
    Forsch Komplementarmed Klass Naturheilkd; 2000 Apr; 7(2):79-84. PubMed ID: 10899744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological changes during the sleep onset period of psychophysiological insomniacs, psychiatric insomniacs, and normal sleepers.
    Lamarche CH; Ogilvie RD
    Sleep; 1997 Sep; 20(9):724-33. PubMed ID: 9406324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization, properties and multivariate functions of delta-sleep-inducing peptide (DSIP).
    Schoenenberger GA
    Eur Neurol; 1984; 23(5):321-45. PubMed ID: 6548966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of DSIP- (delta sleep-inducing peptide) and P-DSIP-like (phosphorylated) immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type, multi-infarct syndrome, communicating hydrocephalus and Parkinson's disease.
    Ernst A; Cramer H; Strubel D; Kuntzmann F; Schoenenberger GA
    J Neurol; 1987 Oct; 235(1):16-21. PubMed ID: 2448424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Delta sleep-inducing peptide. Effective in sleep disorders, stress, chronic pain and substance dependence?].
    Uhl D
    Med Monatsschr Pharm; 1987 Sep; 10(9):289-91. PubMed ID: 3657697
    [No Abstract]   [Full Text] [Related]  

  • 17. Diurnal rhythm of plasma delta-sleep-inducing peptide in humans: evidence for positive correlation with body temperature and negative correlation with rapid eye movement and slow wave sleep.
    Friedman TC; Garcia-Borreguero D; Hardwick D; Akuete CN; Stambuk MK; Dorn LD; Starkman MN; Loh YP; Chrousos GP
    J Clin Endocrinol Metab; 1994 May; 78(5):1085-9. PubMed ID: 8175965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The delta-sleep inducing peptide and its effect on the electroencephalogram and power spectrum density in rats with metaphit-induced epilepsy].
    Stanojlovic O; Zivanovic D; Susic V
    Srp Arh Celok Lek; 2001; 129(5-6):114-8. PubMed ID: 11797457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin replacement therapy of elderly insomniacs.
    Haimov I; Lavie P; Laudon M; Herer P; Vigder C; Zisapel N
    Sleep; 1995 Sep; 18(7):598-603. PubMed ID: 8552931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased delta-sleep and plasma delta-sleep-inducing peptide in patients with Cushing syndrome.
    Friedman TC; GarcĂ­a-Borreguero D; Hardwick D; Akuete CN; Doppman JL; Dorn LD; Barker CN; Yanovski JA; Chrousos GP
    Neuroendocrinology; 1994 Dec; 60(6):626-34. PubMed ID: 7700506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.